Have you evaluated the performance of Eli Lilly's (LLY) international operations during the quarter that concluded in September 2025? Considering the extensive worldwide presence of this drugmaker, ...

Patients presenting to the emergency department with esophageal food impaction commonly do not receive an esophageal biopsy to diagnose EoE, representing a missed diagnostic opportunity.

The menopausal transition is a pivotal time in women’s health, bringing about profound hormonal, metabolic and physiologic ...

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle ...

Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...

For ocular rosacea, dermatologists can do more than hand off patients to ophthalmology by asking the right questions and ...

The partnership between LillyDirect and Walmart allows patients to pick up Zepbound at Walmart pharmacies at the same self-pay price as online. Sel ...

Eli Lilly and Company announced Wednesday, Oct. 29 a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico.

Eli Lilly shares are trading higher on Monday. The pharmaceutical giant announced a significant European manufacturing expansion.

During the industry’s onshoring rush of the last nine months, Eli Lilly has been among the most aggressive biopharma compa | Eli Lilly is allotting $3 billion to establish an oral medicines ...

Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...